Furthermore to advancing our knowledge of the MoA of Cx611, data out of this finished trial shall provide evidence for the safety, effectiveness and tolerability of Cx611 in individuals with sCABP
Furthermore to advancing our knowledge of the MoA of Cx611, data out of this finished trial shall provide evidence for…